Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The head louse respiratory spiracle is an external anatomical opening located along the thorax and abdomen of the head louse (*Pediculus humanus capitis*) and functions as the primary gateway for air intake into the louse's tracheal system[1][5][7][9]. Head lice possess 14 spiracles (1 thoracic, 6 abdominal pairs). Each spiracle is equipped with specialized structures (valved atrium, occlusor muscle) that can restrict water loss or close upon immersion, contributing to the parasite's resilience against environmental changes and classical drowning approaches[1][5][7]. Suffocant lice treatments (e.g., mineral oils, essential oils) do not act on a molecular binding site but physically occlude these spiracles, leading to death by asphyxiation[1][10]. The spiracle is not a discrete drug target in the molecular pharmacology sense, but is the anatomical feature exploited in non-neurotoxic anti-louse products.
Physical suffocation (drugs block or clog the spiracles, preventing gas exchange and leading to louse death by anoxia)[1][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Head louse respiratory spiracle.